CCL3 and cystic fibrosis: Most importantly, treatment with SPMs of CF macrophages stimulated with S1 protein resulted in a significant reduction in the release of IL-8, MCP-1 and macrophage inflammatory protein MIP-1α (CCL3) and MIP-1β (CCL4) (71).